# FDA Inspection 968502 - Symrise AG - April 22, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/symrise-ag/46ebe67b-971a-42dd-97e0-ef56244936e2
Source feed: FDA_Inspections

> FDA Inspection 968502 for Symrise AG on April 22, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 968502
- Company Name: Symrise AG
- Inspection Date: 2016-04-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1289898 - 2023-12-05](https://www.globalkeysolutions.net/records/fda_inspections/symrise-ag/4866ef97-025b-4705-8512-03eeff01838d)
- [FDA Inspection 1135051 - 2020-07-07](https://www.globalkeysolutions.net/records/fda_inspections/symrise-ag/f5ef07bf-9d42-4869-ba8c-11d486236875)
- [FDA Inspection 1046108 - 2018-03-09](https://www.globalkeysolutions.net/records/fda_inspections/symrise-ag/dff38aca-8cc2-4e18-8148-c6d0c0017d98)
- [FDA Inspection 818239 - 2013-02-05](https://www.globalkeysolutions.net/records/fda_inspections/symrise-ag/ab7f2988-94e3-446d-a1b6-70654ea035ea)

Company: https://www.globalkeysolutions.net/companies/symrise-ag/98cd9c8d-0b68-42ac-a5d1-33ae318aeb6d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c